Literature DB >> 12050325

Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization.

Jeroen J Bax1, Jamshid Maddahi, Don Poldermans, Abdou Elhendy, Jan H Cornel, Eric Boersma, Jos R T C Roelandt, Paolo M Fioretti.   

Abstract

UNLABELLED: 201Tl imaging and dobutamine echocardiography (DE) can both identify viable myocardium. Prediction of functional outcome after revascularization remains suboptimal with either technique because of the relatively low specificity of (201)Tl and low sensitivity of DE. This study was undertaken to develop an optimal testing strategy for prediction of post-revascularization functional outcome.
METHODS: Seventy-three patients (mean [+/-SD] left ventricular ejection fraction [LVEF], 32% +/- 8%) underwent DE and resting (201)Tl SPECT (4-h delayed imaging) before surgical revascularization. Dysfunctional segments with (201)Tl activity > or = 50% or with contractile reserve were considered viable. LVEF was assessed before and 3-6 mo after revascularization.
RESULTS: Analysis of receiver operator characteristic curves showed that the optimum criteria to predict improvement (> or = 5%) in LVEF after revascularization were > or = 6 viable dysfunctional segments (using a 16-segment model) on (201)Tl and > or = 4 segments on DE. Sensitivity and specificity were 84% and 63% for (201)Tl (P < 0.05 vs. DE) and 63% and 85% for DE (P < 0.05 vs. (201)Tl). Changing the (201)Tl criteria to improve specificity to 78% (> or = 8 segments) yielded a low sensitivity of 44%, and changing the DE criteria to improve sensitivity to 84% (> or = 2 segments) lowered specificity to 56%. Two sequential testing strategies were explored to achieve optimal sensitivity and specificity. In strategy 1, 33 (45%) of 73 patients with an intermediate likelihood of viability by (201)Tl (5-8 viable segments) underwent DE. In strategy 2, 31 (42%) of 73 patients with an intermediate likelihood of viability by DE (2-4 viable segments) underwent (201)Tl. For strategy 1, sensitivity did not change significantly (69%), whereas specificity was improved significantly (93%, P < 0.01 vs. (201)Tl). For strategy 2, sensitivity improved significantly (78%, P < 0.05 vs. DE) and specificity remained unchanged (80%).
CONCLUSION: Sequential testing by (201)Tl SPECT and DE in a subgroup of patients with an intermediate likelihood of viability by either test significantly enhanced prediction of post-revascularization improvement of LVEF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050325

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

2.  Factors influencing predictive value of FDG imaging for evaluating myocardial viability.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

3.  Assessment of myocardial viability: more than measurements of radiotracer uptake alone.

Authors:  James A Arrighi
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

4.  Multi-modality imaging for assessment of myocardial viability?

Authors:  Eliana Reyes
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-22       Impact factor: 2.357

Review 5.  Multimodality Imaging of Myocardial Viability.

Authors:  Kinjan Parikh; Alana Choy-Shan; Munir Ghesani; Robert Donnino
Journal:  Curr Cardiol Rep       Date:  2021-01-04       Impact factor: 2.931

Review 6.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

7.  Prediction of functional recovery after revascularization using quantitative gated myocardial perfusion SPECT: a multi-center cohort study in Japan.

Authors:  Kenichi Nakajima; Nagara Tamaki; Yoichi Kuwabara; Masaya Kawano; Ichiro Matsunari; Junichi Taki; Shigeyuki Nishimura; Akira Yamashina; Yoshio Ishida; Hitonobu Tomoike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-27       Impact factor: 9.236

8.  Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR Study.

Authors:  Mariann Gyöngyösi; Georgiana-Aura Giurgea; Bonni Syeda; Silvia Charwat; Beatrice Marzluf; Julia Mascherbauer; Andras Jakab; Abelina Zimba; Márta Sárközy; Noemi Pavo; Heinz Sochor; Senta Graf; Irene Lang; Gerald Maurer; Jutta Bergler-Klein
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.

Authors:  Johannes Boehm; Felix Haas; Robert Bauernschmitt; Stefan Wagenpfeil; Bernhard Voss; Markus Schwaiger; Rüdiger Lange
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-21       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.